Prosecution Insights
Last updated: August 15, 2026

Examiner: FOWLER, ALAN JEROME

Tech Center 1700 • Art Units: 1600 1691 1759

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+35.0% vs TC avg
13
Total Applications
+0.0%
Interview Lift
978
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
24.3%
§102 Novelty
43.2%
§103 Obviousness
29.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18417491 COMPOSITIONS AND METHODS FOR INHIBITING CREATINE TRANSPORT AS A TREATMENT FOR CANCER Non-Final OA Inspirna, Inc.
18560337 DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY Non-Final OA Jazz Pharmaceuticals Research UK Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month